Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 3.50K | 25.80K | 454.30K | 455.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 3.50K | 25.80K | 454.30K | 455.70K |
| Cost of Revenue | 211.90K | 212.70K | 221.20K | 217.30K | 89.90K |
| Gross Profit | -211.90K | -209.20K | -195.40K | 237.00K | 365.80K |
| SG&A Expenses | 1.35M | 1.25M | 1.33M | 1.21M | 1.12M |
| Depreciation & Amortization | 181.40K | 183.30K | 256.00K | 253.50K | 227.00K |
| Other Operating Expenses | 298.70K | 341.70K | 368.90K | 296.20K | 306.20K |
| Total Operating Expenses | 2.04M | 1.99M | 2.17M | 1.97M | 1.74M |
| Operating Income | -2.04M | -1.98M | -2.15M | -1.52M | -1.29M |
| Income Before Tax | -2.04M | -1.98M | -2.15M | -1.52M | -1.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.04 | -1.98 | -2.15 | -1.52 | -1.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 205.90K | 206.40K | 143.20K | 103.00K | 32.20K |
| Net Income | -1.83M | -1.78M | -2.00M | -1.42M | -1.26M |
| EBIT | -2.04M | -1.98M | -2.15M | -1.52M | -1.29M |
| EBITDA | -1.86M | -1.80M | -1.89M | -1.26M | -1.06M |
| EPS Basic | -0.02 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.03 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 479.28M | 371.44M | 371.44M | 371.44M | 371.44M |
| Average Diluted Shares Outstanding | 479.28M | 371.44M | 371.44M | 371.44M | 371.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |